AstraZeneca PLC (AZN) market

AstraZeneca PLC (AZN) is a United Kingdom-based biopharmaceuticals company with shares or depositary interests associated with NASDAQ. It develops oncology, cardiovascular, renal, respiratory, immunology, vaccine, and rare-disease medicines with a large global clinical pipeline. Investors commonly compare it with LLY, NVO, PFE, UNH to evaluate sector exposure, business-model concentration, margin drivers, balance-sheet sensitivity, and how company-specific results may differ from broad equity benchmarks. The profile is intended as neutral issuer context for reviewing public-market exposure and related assets.